A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
FOX 9 Minneapolis-St. Paul on MSN4h
Cigna sues, wants leeway to tell customers which pharmacies to useA giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
A yearslong Federal Trade Commission probe, resulting in a report released in July, reported that of the six pharmacy benefit ...
The FTC analyzed data for 51 specialty generic drugs dispensed from 2017-2022 for patients with commercial insurance or Medicare Part D plans managed by CVS Caremark, Express Scripts and OptumRx.
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the ...
In the lawsuit, AG Gentner Drummond outlined 200 individual prescription claims that were reimbursed below acquisition cost ...
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.
The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old Appleton man's death.
The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback